This work demonstrates the synergistic mechanism of co-encapsulating a novel mitochondrial depolarizer and Pgp efflux inhibitor, VES-H8R8, with a pH-sensitive prodrug of doxorubicin in NPs against MDR cancer cells. Here, PGP is linked to cancer.